ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,780Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 122

$552K Total Retail Price of All Prescriptions

Rank: 13 out of 122

320 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

11% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,655 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 406 357 1 1
OMEPRAZOLE 332 246 2 3
WARFARIN SODIUM 281 258 3 9
AMLODIPINE BESYLATE 231 216 4 7
LOSARTAN POTASSIUM 207 177 5 17
LISINOPRIL 206 171 6 2
FUROSEMIDE 205 193 7 5
LEVOTHYROXINE SODIUM 193 181 8 4
HYDROCHLOROTHIAZIDE 181 168 9 6
FLUOXETINE HCL 167 113 10 38
METOPROLOL SUCCINATE 153 127 11 11
GLYBURIDE 152 126 R 12 73
ATENOLOL 151 143 13 10
ZOLPIDEM TARTRATE 140 83 14 19
PREDNISONE 123 90 15 24
LOSARTAN-HYDROCHLOROTHIAZIDE 121 109 16 55
CITALOPRAM HBR 121 99 16 15
GABAPENTIN 120 75 18 12
POTASSIUM CHLORIDE 113 104 19 22
HYDROCODONE-ACETAMINOPHEN 112 37 S3 20 16
ALLOPURINOL 108 108 21 33
DEXTROSE WITH SODIUM CHLORIDE 105 105 10 22 136
DIOVAN 83 64 23 40
METOPROLOL TARTRATE 81 67 24 8
TAMSULOSIN HCL 80 70 25 26
DONEPEZIL HCL 75 75 26 25
OXYCODONE-ACETAMINOPHEN 73 44 S2 27 41
IBUPROFEN 71 34 28 68
SERTRALINE HCL 70 58 29 18
NAPROXEN 66 48 30 120
METFORMIN HCL 66 58 30 14
DICYCLOMINE HCL 65 48 32 126
OXYCODONE HCL 62 0 S2 33 30
LANTUS 59 43 34 36
CARVEDILOL 58 45 35 56
SINGULAIR 57 46 36 112
FINASTERIDE 57 46 36 76
SPIRIVA 53 51 38 29
DIGOXIN 52 52 39 74
VENLAFAXINE HCL ER 50 40 40 54
CELEBREX 50 44 40 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.